Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)

Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)

Bibliographic Details
Main Authors: Rudwaleit, M, Claudepierre, P, Loza, E, Wordsworth, P, Olivieri, I, Wong, R, Oezer, U, Kary, S, Kupper, H
Format: Conference item
Published: 2008

Similar Items

Similar Items